Abstract
Since 2001, the unrestricted use of HIVNET012 has been recommended for the prevention of mother-to-child transmission in low-resource settings, despite the lack of validated efficacy data outside research settings. We implemented the nevirapine regimen in a real-life situation in Kenya. The perinatal HIV-1 transmission rate at 14 weeks was 18.1%, similar to the 21.7% before the intervention. These data call for further evaluation of the simple nevirapine regimen in field conditions, and underline the need for alternative strategies.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1854-1856 |
| Number of pages | 3 |
| Journal | AIDS |
| Volume | 18 |
| Issue number | 13 |
| DOIs | |
| Publication status | Published - 3 Sept 2004 |
| Externally published | Yes |